Studies have shown that GLP-1R agonists not only promote insulin secretion and exert glucose-lowering effects but also effectively delay gastric emptying, reduce intestinal motility, activate neural pathways in the hypothalamus and appetite regulation areas, resulting in decreased appetite and reduced food intake, thus treating obesity
While Novo Nordisk successfully defended the validity of its compound patent in the Beijing Supreme Peoples Court in late 2025, the patent is still set to expire on March 20, 2026
In clinical studies, Triamino Copper Complex, a patented peptide blend of copper and amino acids, has been shown to boost hair health and revitalize its appearance
By slowing melanin production, glutathione helps lighten the skin and reduce the visibility of blemishes, scars, and sun spots